Christopher Horan serves as Executive at Dermira, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Horan has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 12, 2025 involved receiving (via award) 107,156 shares valued at $0.
Christopher Horan currently holds 185,339 shares of Dermira, Inc. (DERM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Horan has been a net neutral trader of DERM stock. They have purchased $0 and sold $0 worth of shares.
Christopher Horan's most recent insider trade was on Dec 12, 2025, when they sold 107,156 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.25 |
| Discretionary |
| Aug 15, 2025 | ARTV | $9.8K | Payment | 3,577 | $2.75 | Discretionary |
| May 15, 2025 | ARTV | $2.9K | Payment | 1,341 | $2.13 | Discretionary |
| Sep 12, 2024 | ARTV | $0 | Award | 25,000 | $N/A | Discretionary |
| Feb 20, 2020 | DERM | $401.3K | Disposition | 21,400 | $18.75 | Discretionary |
| May 17, 2019 | DERM | $96.8K | Payment | 9,222 | $10.50 | Discretionary |
| May 17, 2019 | DERM | $0 | Option Exercise | 26,667 | $N/A | Discretionary |